Abstract
Background
During the past decade, there has been growing interest in complementary and alternative medicine (CAM) among cancer patients and it is being integrated more frequently within conventional cancer centers. The long-term effect of mind-body therapies on quality of life (QoL), depression, anxiety, and fatigue was tested prospectively in this study.
Patients and methods
Cancer patients who received six weekly sessions of CAM during their oncological treatments participated in the study. The Hospital Anxiety and Depression Scale (HADS), Brief Fatigue Inventory (BFI) and QoL-EORTC-C30 were completed during the intervention and follow-up period.
Results
Over a two-year period, 163 patients entered the study, 135 of whom completed all six CAM sessions. An improvement was demonstrated in the median of BFI from 4.8 to 3.9 (p < 0.001), HADS-Anxiety from 8 to 7 (p < 0.001) and HADS-Depression from 7 to 6 (p < 0.001) after 12 weeks. In addition, the median of global QoL improved from 50 to 67 (p < 0.001), and a significant improvement was noticed in several parameters on the functioning and symptoms scales of the QoL-EORTC-C30.
Conclusion
Cancer patients who completed six weekly sessions of CAM improved significantly on measured outcomes, regardless of their demographic characteristics.
Similar content being viewed by others
References
Linden W, Vodermaier A, MacKenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141:343–351
Maguire P (2000) Managing psychological morbidity in cancer patients. Eur J Cancer 36:556–558
Campos MPO, Hassan BJ, Riechelmann R, Del Giglio A (2011) Cancer-related fatigue: a practical review. Ann Oncol 22:1273–1279
Stone PC, Minton O (2008) Cancer-related fatigue. Eur J Cancer 44:1097–1104
Jacobsen PB, Jim HS (2008) Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA: Cancer J Clin 58:214–230. doi:10.3322/CA.2008.0003
Stanton AL, Luecken LJ, Mackinnon DP, Thompson EH (2013) Mechanisms in psychosocial interventions for adults living with cancer: opportunity for integration of theory, research, and practice. J Consult Clin Psychol 81:318–335
Ben-Arye E, Steinmetz D, Ezzo J (2007) Two women and cancer: the need for addressing spiritual well-being in cancer care. Fam Syst Health 25:1–9
Mason S, Tovey P, Long AF (2002) Evaluating complementary medicine: methodological challenges of randomised controlled trials. BMJ 325:832–834
The National Centre for Complementary and Alternative Medicine (NCCAM) website. available at: http://nccam.nih.gov/health/whatiscam
Gage H, Storey L, Mcdowell C, Maguire G, Williams P, Faithfull S, Thomas H, Poole K (2009) Integrated care: utilisation of complementary and alternative medicine within a conventional cancer treatment centre. Complement Ther Med 17:84–91
Molassiotis A, Panteli V, Patiraki E et al (2006) Complementary and alternative medicine use in lung cancer patients in eight European countries. Complement Ther Clin Pract 12:34–39
Scott JA, Kearney N, Hummerston S, Molassiotis A (2005) Use of complementary and alternative medicine in patients with cancer: a UK survey. Eur J Oncol Nurs 9:131–137
Molassiotis A, Fernandez-Ortega P, Pud D et al (2005) Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complement Ther Med 13:251–257
Ernst E (1995) Complementary cancer treatments: hope or hazard? Clin Oncol 7:259–263
Akyol AD, Öz B (2011) The use of complementary and alternative medicine by patients with cancer: in Turkey. Complement Ther Clin Pract 17:230–234
Pud D, Kaner E, Morag A, Ben-Ami S, Yaffe A (2005) Use of complementary and alternative medicine among cancer patients in Israel. Eur J Oncol Nurs 9:124–130
DiGianni LM, Garber JE, Winer EP (2002) Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20:34S–38S
Roberts CS, Baker F, Hann D et al (2005) Patient-physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol 23:35–60
Egan B, Gage H, Hood J, Poole K, McDowell C, Maguire G, Storey L (2012) Availability of complementary and alternative medicine for people with cancer in the British national health service: results of a national survey. Complement Ther Clin Pract 18:75–80
Micke O, Bruns F, Glatzel M, Schonekaes K, Micke P, Mucke R, Buntzel J (2009) Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med 1:19–25
Jeon SW, Kim KS, Nam HJ (2012) Long-term effect of acupuncture for treatment of tinnitus: a randomized, patient- and assessor-blind, sham-acupuncture-controlled, pilot trial. J Altern Complement Med 18:693–699
Carlsson CP, Sjölund BH (2001) Acupuncture for chronic low back pain: a randomized placebo-controlled study with long-term follow-up. Clin J Pain 17:296–305
Nedeljkovic M, Tian L, Ji P, Déglon-Fischer A, Stute P, Ocon E, Birkhäuser M, Ausfeld-Hafter B (2014) Effects of acupuncture and Chinese herbal medicine (Zhi Mu 14) on hot flushes and quality of life in postmenopausal women: results of a four-arm randomized controlled pilot trial. Menopause 21:15–24
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5:649–655
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 53:361–370
Snaith RP (2003) The hospital anxiety and depression scale. Health Qual Life Outcomes 1:29
Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85:1186–1196
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Maringwa JT, Quinten C, King M, EORTC PROBE project and the Lung Cancer Group et al (2011) Minimal important differences for interpreting health-related quality of life scores from the EORTC-QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer 19:1753–1760
Scott NW, Fayers PM, Aaronson NK, et al (2008) Manual for EORTC QLQ-C30. European Organization for Research and Treatment of Cancer-Quality of Life Group
Le Pechoux C, Laplanche A, Faivre-Finn C et al (2011) Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol 22:1154–1163
Molassiotis A, Fernadez-Ortega P, Pud D et al (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:655–663
Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook P (2000) The unmet supportive care needs of patients with cancer. Cancer 88:226–237
Zakowski SG, Harris C, Krueger N, Laubmeier KK, Garrett S, Flanigan R, Johnson P (2003) Social barriers to emotional expression and their relations to distress in male and female cancer patients. Br J Health Psychol 8:271–286
Howren MB, Christensen AJ, Karnell LH, Funk GF (2010) Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms. Health Psychol 29:65–71
Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54:269–282
Hopko DR, Armento ME, Robertson SM et al (2011) Brief behavioral activation and problem-solving therapy for depressed breast cancer patients: randomized trial. J Consult Clin Psychol 79:834–849
Piet J, Würtzen H, Zachariae R (2012) The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol 80:1007–1020
Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW (2012) Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial. JCO 30(12):1335–1342
Littman AJ, Bertram LC, Ceballos R, Ulrich CM, Ramaprasad J, McGregor B, McTiernan A (2012) Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures. Support Care Cancer 20:267–277
Oh B, Butow P, Mullan B, Clarke S, Beale P, Pavlakis N, Kothe E, Lam L, Rosenthal D (2010) Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Ann Oncol 21:608–614
Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder DW, Filshie J, Ream E, Richardson A (2012) Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol 30:4470–4476
Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin MJ (2011) Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer 11:196
Burstein H, Gelber S, Guadagnoli E, Weeks J (1999) Use of alternative medicine by women with early stage breast cancer. New Engl J Med 340:1733–1739
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bar-Sela, G., Danos, S., Visel, B. et al. The effect of complementary and alternative medicine on quality of life, depression, anxiety, and fatigue levels among cancer patients during active oncology treatment: phase II study. Support Care Cancer 23, 1979–1985 (2015). https://doi.org/10.1007/s00520-014-2560-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2560-1